Kliniske studier for Blodkreft i Alabama
11 studier for Blodkreft søker deltakere på steder i Alabama.
Byer i Alabama
Offisiell studietekst (engelsk)
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Alabama Birmingham, Birmingham
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04634552Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
RekruttererFase 3
Alder 18 til 71 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07504458Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT04588922A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Alabama at Birmingham, Birmingham
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Children's Hospital of Alabama, Birmingham
RekruttererFase 3
Alder 2 til 18 · Alle kjønn · Oppdatert 5. mai 2026 · NCT05711667Cognitive Training Intervention and Attitudes Towards Genetics
- University of Alabama at Birmingham, Birmingham
Rekrutterer
Alder 21 og eldre · Alle kjønn · Oppdatert 20. apr. 2026 · NCT03094026UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- University of Alabama at Birmingham, Birmingham
RekruttererFase 1
4 Weeks – 75 Years · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06047886Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- University of Alabama at Birmingham, Birmingham
RekruttererFase 1
Alder 18 til 75 · Alle kjønn · Oppdatert 4. mar. 2026 · NCT07044544Diet and Cognitive Training in Hematologic Cancer Survivors
- University of Alabama at Birmingham, Birmingham
Rekrutterer
Alder 21 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT05708716BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. okt. 2025 · NCT06472089Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- University of Alabama at Birmingham, Birmingham
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. nov. 2024 · NCT06034275Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.